Litu Zhang

Guangxi Medical University

H指数:17

被引数:1,211

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human mesenchymal stem cell-derived miR-3614-5p exosomes suppress progression of colorectal cancer by targeting IL7Rα

人源间充质干细胞来源的miR-3614-5p外泌体通过靶向IL7Rα抑制结直肠癌进展

Journal of Translational Medicine

IF7.5

2026-05-210

OAAI

Dual-Release Free Iron and Breakdown of Ferroptosis Defenses to Achieve Ferroptosis Cascade Storms for Potent Antitumor Therapy

双释放游离铁和破坏铁死亡防御以实现铁死亡级联风暴，用于强效抗肿瘤治疗

ADVANCED FUNCTIONAL MATERIALS

IF0

2025-01-191

PRE

PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy

PdRu双金属纳米合金，具有增强的光热效应，用于放大的ROS介导的肿瘤治疗

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY

IF4.8

2025-01-032

eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

BMC CANCER

IF3.4

2024-07-120

OAAI

Chemodynamic PtMn Nanocubes for Effective Photothermal ROS Storm a Key Anti-Tumor Therapy in-vivo

用于有效光热ROS的化学动力学PtMn纳米立方体是体内抗肿瘤治疗的关键

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2024-05-012

OAAI

GSH-Triggered/Photothermal-Enhanced H2S Signaling Molecule Release for Gas Therapy

PHARMACEUTICS

IF5.5

2023-10-104

OAAI

The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma

HELIYON

IF3.6

2023-03-010

OAAI

High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-07-116

OAAI

Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage I-III Breast Cancer Receiving Chemotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-248

OAAI

The High Ratio of the Plasma miR-96/miR-99b Correlated With Poor Prognosis in Patients With Metastatic Colorectal Cancer

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-01-0310

OAAI

Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2021-07-088

OAAI

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19

PHARMACOLOGY & THERAPEUTICS

IF12.5

2020-12-0167

OAAI

Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma

血浆HSP90α 水平检测对肝细胞癌的诊断价值

BMC CANCER

IF3.4

2020-01-0236

OAAI

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

Signal Transduction and Targeted Therapy

IF52.7

2020-01-010

OAAI

Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients

胃癌和大肠癌患者血清TK1、CEA、CA 19-9和CA 72-4水平的临床意义及诊断价值

JOURNAL OF CANCER

IF3.2

2018-01-0194

OAAI

Flowers of Camellia nitidissima cause growth inhibition, cell-cycle dysregulation and apoptosis in a human esophageal squamous cell carcinoma cell line

MOLECULAR MEDICINE REPORTS

IF3.5

2016-06-1024

OAAI

Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues

ONCOLOGY REPORTS

IF3.9

2015-05-0811

OAAI

Haploinsufficiency of TAB2 Causes Congenital Heart Defects in Humans

AMERICAN JOURNAL OF HUMAN GENETICS

IF8.1

2010-06-0191

OAAI

Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development

EUROPEAN JOURNAL OF HUMAN GENETICS

IF4.6

2009-01-2826

OAAI

High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease

JOURNAL OF MEDICAL GENETICS

IF3.7

2008-11-01122

PREAI

Litu Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向